CompletedPhase 4

The COPD Patient Management European Trial (COMET)

France346 participantsStarted 2010-09

Plain-language summary

The goal of the study is to evaluate a Home-Based Disease Management program specifically developed for patients with Gold III/IV COPD. By improving disease knowledge, awareness of significant clinical deterioration and self-management skills for patients, this Home-Based COPD Management Program is expected to reduce the severity of exacerbations, the need for emergency hospitalisations, thus demonstrating the efficacy and the cost effectiveness of this intervention.

Who can participate

Age range35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed Gold III/IV COPD * Current or ex-smoker with a smoking history ≥ 10 pack-years * At least one COPD exacerbation leading to hospitalization in the year before selection. Exclusion Criteria: * LTOT for another reason than COPD * Severe concomitant disorder associated with a limited probability of survival (\< 6 months) * Tracheostomy * Long term oral corticosteroids therapy

What they're measuring

Number of unscheduled hospital days

Timeframe: up to 12 months

Trial details

NCT IDNCT01241526

SponsorAir Liquide Santé International

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2015-02

View on ClinicalTrials.gov More Chronic Obstructive Pulmonary Disease (COPD) trials